FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014092617> ?p ?o ?g. }

• W2014092617 endingPage "1334" @default.
• W2014092617 startingPage "1324" @default.
• W2014092617 abstract "Reversible binding among components of the cellular submembrane cytoskeleton and reversible binding of some of these components with the plasma membrane likely play a role in nonelastic morphological changes and mechanoplastic properties of cells. However, relatively few studies have been devoted to investigating directly the kinetic aspects of the interactions of individual components of the membrane skeleton with the membrane. The experiments described here investigated whether one component of the erythrocyte membrane cytoskeleton, protein 4.1, binds to its sites on the membrane reversibly and if so, whether the different 4.1-binding sites display distinct kinetic behavior. Protein 4.1 is known to stabilize the membrane and to mediate the attachment of spectrin filaments to the membrane. Protein 4.1 previously has been shown to bind to integral membrane proteins band 3, glycophorin C, and to negatively charged phospholipids. To examine the kinetic rates of dissociation of carboxymethyl fluorescein-labeled 4.1 (CF-4.1) to the cytofacial surface of erythrocyte membrane, a special preparation of hemolyzed erythrocyte ghosts was used, in which the ghosts became flattened on a glass surface and exposed their cytofacial surfaces to the solution through a membrane rip in a distinctive characteristic pattern. This preparation was examined by the microscopy technique of total internal reflection/fluorescence recovery after photobleaching (TIR/FRAP). Four different treatments were employed to help identify which membrane binding sites gave rise to the multiplicity of observed kinetic rates. The first treatment, the control, stripped off the native spectrin, actin, 4.1, and ankyrin. About 60% of the CF-4.1 bound to this control binded irreversibly (dissociation time > 20 min), but the remaining approximately 40% binded reversibly with a range of residency times averaging approximately 3 s. The second treatment subjected these stripped membranes to trypsin, which presumably removed most of the band 3. CF-4.1 binded significantly less to these trypsinized membranes and most of the decrease was a loss of the irreversibly binding sites. The third treatment simply preserved the native 4.1 and ankyrin. CF-4.1 binded less to this sample too, and the loss involved both the irreversible and reversible sites. The fourth treatment blocked the gycophorin C sites on the native 4.1-stripped membranes with an antibody. CF-4.1 again binded less to this sample than to a nonimmune serum control, and almost all of the decrease is a loss of irreversible sites. These rest suggest that 1) protein 4.1 binds to membrane or submembrane sites at least in part reversibly ; 2) the most reversible sites are probably not proteinaceous and not glycophorin C, but possibly are phospholipids (especially phosphatidylserine); and 3) TIWRFRAP can successfully examine the fast reversible dynamics of cytoskeletal components binding to biological membranes." @default.
• W2014092617 created "2016-06-24" @default.
• W2014092617 creator A5003144145 @default.
• W2014092617 creator A5087088078 @default.
• W2014092617 date "1994-09-01" @default.
• W2014092617 modified "2023-09-25" @default.
• W2014092617 title "Reversible binding kinetics of a cytoskeletal protein at the erythrocyte submembrane" @default.
• W2014092617 cites W1485258003 @default.
• W2014092617 cites W1518808549 @default.
• W2014092617 cites W1547860251 @default.
• W2014092617 cites W1554532255 @default.
• W2014092617 cites W1559532543 @default.
• W2014092617 cites W1561589021 @default.
• W2014092617 cites W1601961990 @default.
• W2014092617 cites W1626758822 @default.
• W2014092617 cites W1973210281 @default.
• W2014092617 cites W1974378714 @default.
• W2014092617 cites W1991720127 @default.
• W2014092617 cites W1993308893 @default.
• W2014092617 cites W2005101090 @default.
• W2014092617 cites W2010550024 @default.
• W2014092617 cites W2021816748 @default.
• W2014092617 cites W2024184910 @default.
• W2014092617 cites W2024983674 @default.
• W2014092617 cites W2030386167 @default.
• W2014092617 cites W2032977054 @default.
• W2014092617 cites W2035625594 @default.
• W2014092617 cites W2055940452 @default.
• W2014092617 cites W2056847422 @default.
• W2014092617 cites W2057945001 @default.
• W2014092617 cites W2065286181 @default.
• W2014092617 cites W2078636712 @default.
• W2014092617 cites W2083942126 @default.
• W2014092617 cites W2090949030 @default.
• W2014092617 cites W4236631361 @default.
• W2014092617 doi "https://doi.org/10.1016/s0006-3495(94)80604-6" @default.
• W2014092617 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1225489" @default.
• W2014092617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7811947" @default.
• W2014092617 hasPublicationYear "1994" @default.
• W2014092617 type Work @default.
• W2014092617 sameAs 2014092617 @default.
• W2014092617 citedByCount "25" @default.
• W2014092617 countsByYear W20140926172013 @default.
• W2014092617 countsByYear W20140926172016 @default.
• W2014092617 countsByYear W20140926172020 @default.
• W2014092617 countsByYear W20140926172021 @default.
• W2014092617 countsByYear W20140926172023 @default.
• W2014092617 crossrefType "journal-article" @default.
• W2014092617 hasAuthorship W2014092617A5003144145 @default.
• W2014092617 hasAuthorship W2014092617A5087088078 @default.
• W2014092617 hasBestOaLocation W20140926171 @default.
• W2014092617 hasConcept C104317684 @default.
• W2014092617 hasConcept C121332964 @default.
• W2014092617 hasConcept C121381206 @default.
• W2014092617 hasConcept C12554922 @default.
• W2014092617 hasConcept C142669718 @default.
• W2014092617 hasConcept C144647389 @default.
• W2014092617 hasConcept C148898269 @default.
• W2014092617 hasConcept C1491633281 @default.
• W2014092617 hasConcept C152900378 @default.
• W2014092617 hasConcept C170493617 @default.
• W2014092617 hasConcept C182800266 @default.
• W2014092617 hasConcept C185592680 @default.
• W2014092617 hasConcept C26659971 @default.
• W2014092617 hasConcept C2776589458 @default.
• W2014092617 hasConcept C31332276 @default.
• W2014092617 hasConcept C41625074 @default.
• W2014092617 hasConcept C50244902 @default.
• W2014092617 hasConcept C55493867 @default.
• W2014092617 hasConcept C62520636 @default.
• W2014092617 hasConcept C67982717 @default.
• W2014092617 hasConcept C86803240 @default.
• W2014092617 hasConcept C91881484 @default.
• W2014092617 hasConceptScore W2014092617C104317684 @default.
• W2014092617 hasConceptScore W2014092617C121332964 @default.
• W2014092617 hasConceptScore W2014092617C121381206 @default.
• W2014092617 hasConceptScore W2014092617C12554922 @default.
• W2014092617 hasConceptScore W2014092617C142669718 @default.
• W2014092617 hasConceptScore W2014092617C144647389 @default.
• W2014092617 hasConceptScore W2014092617C148898269 @default.
• W2014092617 hasConceptScore W2014092617C1491633281 @default.
• W2014092617 hasConceptScore W2014092617C152900378 @default.
• W2014092617 hasConceptScore W2014092617C170493617 @default.
• W2014092617 hasConceptScore W2014092617C182800266 @default.
• W2014092617 hasConceptScore W2014092617C185592680 @default.
• W2014092617 hasConceptScore W2014092617C26659971 @default.
• W2014092617 hasConceptScore W2014092617C2776589458 @default.
• W2014092617 hasConceptScore W2014092617C31332276 @default.
• W2014092617 hasConceptScore W2014092617C41625074 @default.
• W2014092617 hasConceptScore W2014092617C50244902 @default.
• W2014092617 hasConceptScore W2014092617C55493867 @default.
• W2014092617 hasConceptScore W2014092617C62520636 @default.
• W2014092617 hasConceptScore W2014092617C67982717 @default.
• W2014092617 hasConceptScore W2014092617C86803240 @default.
• W2014092617 hasConceptScore W2014092617C91881484 @default.
• W2014092617 hasIssue "3" @default.
• W2014092617 hasLocation W20140926171 @default.
• W2014092617 hasLocation W20140926172 @default.

• next